PTC Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $178,875 | $1,176,096 | $213,172 | $196,786 |
Gross Profit | 163,394 | 1,163,234 | 251,284 | 185,938 |
EBITDA | -34,957 | 970,225 | -46,875 | -49,896 |
EBIT | -42,540 | 963,004 | -53,639 | -56,382 |
Net Income | -64,849 | 866,562 | -65,886 | -106,654 |
Net Change In Cash | 178,875 | 1,176,096 | 213,172 | 196,786 |
Free Cash Flow | -58,842 | 867,571 | -36,501 | -22,751 |
Cash | 1,017,386 | 1,480,231 | 779,709 | 526,001 |
Basic Shares | 78,151 | 86,385 | 77,201 | 76,925 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $806,780 | $937,822 | $698,801 | $538,593 |
Gross Profit | 749,382 | 649,701 | 654,123 | 506,265 |
EBITDA | -120,463 | -330,340 | -367,780 | -368,184 |
EBIT | -196,126 | -566,930 | -496,616 | -432,318 |
Net Income | -363,295 | -626,604 | -559,017 | -523,901 |
Net Change In Cash | 806,780 | 937,822 | 698,801 | 538,593 |
Cost of Revenue | 101,479 | -11,273 | ||
Free Cash Flow | -114,190 | -279,037 | -509,114 | -336,663 |
Cash | 779,709 | 594,001 | 279,834 | 773,376 |
Basic Shares | 76,845 | 74,838 | 71,728 | 70,466 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.83 |
2025-03-31 | $10.04 |
2024-12-31 | -$0.34 |
